Director, Clinical Leader, Neuroscience at Janssen
Dr. Ramchandren is a board-certified neurologist and neuromuscular disorders specialist, Master of Science in clinical trial design and statistical analysis.
Director of Clinical Development, experienced in the design, oversight and strategic execution of late-phase trials. Leader of cross-functional matrix teams, oversight of vendors and trial operations including medical, safety, data quality monitoring, and rater training, interaction with KOLs, PAGs, regulatory authorities, author papers, abstracts, and scientific presentations, clinical development plans, protocols, clinical study reports, and all essential documents for IND regulatory filings globally.
SME in genetic and autoimmune neuromuscular disorders. Research and clinical expertise in pediatric and adult Duchenne, SMA, Muscular Dystrophy, ALS, CMT, myasthenia gravis, myositis, CIDP, MGUS neuropathy and paraneoplastic neuromuscular disorders. Previously Director of MDA Care Center and CMT Center of Excellence, with experience as PI on investigator-initiated and industry-sponsored trials. Clinical experience in MS, Parkinson’s, Alzheimer’s, epilepsy, and stroke.